Overview

  • 15

    No. of Countries we operate
  • 11,000

    Employees
  • 50000 Millions

    Turnover

Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. Today, we have 11,000 employees and are heading towards a turnover of INR 50000 million.

Our vast network includes 50 C&F agents and 7500+ stockists. We provide a wide range of products – Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories – across the nation.

We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, PregaNews, Adiction, Gas-O-Fast, Kaloree 1, and our latest launch, Heal-O-Kind.

In 2007, Mankind acquired Magnet Labs Pvt Ltd, establishing a marketing presence in the antipsychotic segment. Later in January 2010, the company acquired the former brand of UCB Belgium, Longifene.

Today, Mankind operates in 11 overseas destinations across Asia, Africa, South-East Asia and Gulf countries. Targeting the competitive markets of Commonwealth Independent States, the company will soon begin operations in regions like Uzbekistan and Tajikistan.

Since its inception Mankind aspires to be customer-centric and a leader in the Indian markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare.

Our Total Quality Management system adheres to cGMP regulation and we endeavour to achieve and present the best quality standards in the industry. Our unique assets and skills are always oriented towards developing novel and differentiating scientific solutions through innovative products designed to improve the quality of life.

Mankind aspires to aid the community in leading a healthy life through two parallel objectives: formulating, developing and commercializing medicines, and delivering affordable and accessible medication that satisfies urgent medical needs.